SCHEMBL6978080

SCHEMBL6978080

O=C(O)C1CC(SC(c2ccccc2)(c2ccccc2)c2ccccc2)CN1S(=O)(=O)c1ccc2ccccc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 4/20 0.47
AKR1C1 Q04828 1/20 0.47
MCL1 Q07820 2/20 0.43
ECE1 P42892 2/20 0.42
MME P08473 1/20 0.42
ACE P12821 1/20 0.42
LMNA P02545 2/20 0.41
ALDH1A1 P00352 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HCRTR1 O43613 1/20 0.40
HCRTR2 O43614 1/20 0.40
CCR4 P51679 3/20 0.39
HPGD P15428 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
KDM4E B2RXH2 1/20 0.39
CTDSP1 Q9GZU7 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5402095 1.00 AKR1C3 (0.47) AKR1C3AKR1C1MCL1ECE1MME
SCHEMBL5723228 0.89 MME (0.47) AKR1C3AKR1C1MCL1ECE1MME
SCHEMBL6968343 0.89 MME (0.43) AKR1C3AKR1C1MCL1ECE1MME
SCHEMBL5723986 0.89 MME (0.47) AKR1C3AKR1C1MCL1ECE1MME
SCHEMBL5422653 0.89 MME (0.43) AKR1C3AKR1C1MCL1ECE1MME
SCHEMBL6968348 0.89 MME (0.43) AKR1C3AKR1C1MCL1ECE1MME
SCHEMBL7138285 0.87 AKR1C3 (0.52) AKR1C3AKR1C1MCL1ECE1MME
SCHEMBL7141900 0.87 AKR1C3 (0.52) AKR1C3AKR1C1MCL1ECE1MME
SCHEMBL5399051 0.86 AKR1C3 (0.39) AKR1C3AKR1C1MCL1ECE1MME
SCHEMBL5399056 0.86 AKR1C3 (0.39) AKR1C3AKR1C1MCL1ECE1MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1317428-A1 PYRROLIDINE-2-CARBOXYLIC ACID HYDRAZIDE DERIVATIVES FOR USE AS METALLOPROTEASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2003-06-11 EP disclosed
EP-1303486-A1 PYRROLIDINE DERIVATIVES AS METALLOPROTEASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2003-04-23 EP disclosed
EP-1303485-A1 PYRROLIDINE DERIVATIVES AS INHIBITORS OF ENDOTHELIN-CONVERTING ENZYME F. HOFFMANN-LA ROCHE AG (CH) 2003-04-23 EP disclosed
WO-2002008185-A1 PYRROLIDINE DERIVATIVES AS METALLOPROTEASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2002-01-31 WO disclosed
WO-2002006222-A1 PYRROLIDINE DERIVATIVES AS INHIBITORS OF ENDOTHELIN-CONVERTING ENZYME F. HOFFMANN-LA ROCHE AG (CH) 2002-01-24 WO disclosed
WO-2002006224-A1 PYRROLIDINE-2-CARBOXYLIC ACID HYDRAZIDE DERIVATIVES FOR USE AS METALLOPROTEASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2002-01-24 WO disclosed